Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies
The effects of coronavirus disease 2019 (COVID-19), a highly transmissible infectious respiratory disease that has initiated an ongoing pandemic since early 2020, do not always end in the acute phase. Depending on the study referred, about 10%-30% (or more) of COVID-19 survivors may develop long-COV...
Saved in:
Main Authors: | Yong, Shin Jie *, Liu, Shiliang |
---|---|
Format: | Article |
Published: |
Wiley
2022
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/3116/ https://doi.org/10.1002/rmv.2315 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory and vascular biomarkers in post-COVID-19 syndrome: A systematic review and meta-analysis of over 20 biomarkers
by: Yong, Shin Jie *, et al.
Published: (2023) -
Association of maternal depression and hypothyroidism with infant gastroschisis: a population-based cohort study in Canada
by: Liu, Shiliang, et al.
Published: (2023) -
Evaluation of PAIusp subtyping to characterize uropathogenic E. coli isolates
by: Yun, Mei Lai, et al.
Published: (2016) -
Does HLA-B*27 subtypes and ethnicity matter in Ankylosing Spondylitis?
by: Sulaiman, Salsabil, et al.
Published: (2017) -
Genetics of ankylosing spondylitis: does HLA-B *27allele subtype matter?
by: Too, Chun Lai, et al.
Published: (2017)